Abbott, Johnson & Johnson bulk up in Europe

U.S. healthcare companies Abbott Laboratories (ABT.N)(ABT.F) and Johnson & Johnson (JNJ.N) announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday aimed at securing vaccines and other products

Wall Street to open higher with M&A boost

U.S. stocks were set for a higher open on Monday as more merger and acquisition activity and the last days of the third quarter encouraged investors following three sessions of losses. Xerox

G20 seeks balanced growth

G20 leaders promised last week to rebalance world growth, and upcoming data will show that it is already happening, although not for the reasons they want. While the world's economic leaders would

Germany’s Merkel says committed to tax cuts

German Chancellor Angela Merkel, whose conservatives on Sunday won enough votes to form a coalition with the pro-business Free Democrats, said on Monday she was committed to cutting tax but refused to

Miners, banks drag FTSE down 0.5 pct

Britain's top share index fell early on Monday, tracking weaker showings in Asia after falls on Wall Street on Friday, with declines by miners and banks countering a rally from pharmaceutical stocks.

Stock futures point to weaker start

Stock futures pointed to a weaker start for Wall Street on Monday. Futures for the Dow, the S&P 500 and the Nasdaq were down 0.2-0.4 percent by 3:58 a.m. EDT. Belgian drugs,